Defects in intratumoral arginine metabolism attenuate the replication and therapeutic efficacy of oncolytic myxoma virusParker Dryja(Medical University of South Carolina), Eric Bartee(University of New Mexico)Journal for ImmunoTherapy of CancerJune 1, 202310.1136/jitc-2022-006388Cited by 8SaveCiteExport RISWatch citationsRelated PapersHigh Levels of Extracellular Potassium Can Delay Myxoma Virus Replication by Preventing Release of Virions from the Endosomes|Journal of Virology|2023|1